Prolia® is an FDA-approved therapy for patients with cancer treatment-induced bone loss (CTIBL) due to hormone ablation. Review dosing information and clinical trial results.
Prolia® is an FDA-approved therapy for patients with cancer treatment-induced bone loss (CTIBL) due to hormone ablation. Review dosing information and clinical trial results.
Prolia® is an FDA-approved therapy for patients with cancer treatment-induced bone loss (CTIBL) due to hormone ablation. Review dosing information and clinical trial results.